Literature DB >> 33745447

Diagnostic precision and identification of rare diseases is dependent on distance of residence relative to tertiary medical facilities.

Anna-Lena Walter1, Florent Baty2, Frank Rassouli2, Stefan Bilz3, Martin Hugo Brutsche2.   

Abstract

BACKGROUND: Diagnostic precision and the identification of rare diseases is a daily challenge, which needs specialized expertise. We hypothesized, that there is a correlation between the distance of residence to the next tertiary medical facility with highly specialized care and the diagnostic precision, especially for rare diseases.
RESULTS: Using a nation-wide hospitalization database, we found a negative association between diagnostic diversity and travel time to the next tertiary referral hospital when including all cases throughout the overall International Classification of Diseases version 10 German Modification (ICD-10-GM) diagnosis codes. This was paralleled with a negative association of standardized incidence rates in all groups of rare diseases defined by the Orphanet rare disease nomenclature, except for rare teratologic and rare allergic diseases.
CONCLUSION: Our findings indicate a higher risk of being mis-, under- or late diagnosed especially in rare diseases when living more distant to a tertiary medical facility. Greater distance to the next tertiary medical facility basically increases the chance for hospitalization in a non-comprehensive regional hospital with less diagnostic capacity, and, thus, impacts on adapted health care access. Therefore, solutions for overcoming the distance to specialized care as an indicator of health care access are a major goal in the future.

Entities:  

Keywords:  Diagnostic diversity; Distance to center; Rare diseases

Mesh:

Year:  2021        PMID: 33745447      PMCID: PMC7983389          DOI: 10.1186/s13023-021-01769-6

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  31 in total

Review 1.  Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries.

Authors:  David Beran; Heather J Zar; Christophe Perrin; Ana M Menezes; Peter Burney
Journal:  Lancet Respir Med       Date:  2015-02       Impact factor: 30.700

2.  The Association of Geographic Dispersion with Outcomes among Hospitalized Pulmonary Service Patients.

Authors:  Rachel Kohn; Michael O Harhay; Gary E Weissman; George L Anesi; Brian Bayes; Hummy Song; Scott D Halpern; S Ryan Greysen; Meeta Prasad Kerlin
Journal:  Ann Am Thorac Soc       Date:  2020-02

Review 3.  Policies and actions to tackle rare diseases at European level.

Authors:  Antoni Montserrat; Domenica Taruscio
Journal:  Ann Ist Super Sanita       Date:  2019 Jul-Sep       Impact factor: 1.663

Review 4.  Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities.

Authors:  Johan Herlitz; Birgitta Wireklintsundström; Angela Bång; Annika Berglund; Leif Svensson; Christian Blomstrand
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-09-06       Impact factor: 2.953

5.  Primary care physician specialty referral decision making: patient, physician, and health care system determinants.

Authors:  Christopher B Forrest; Paul A Nutting; Sarah von Schrader; Charles Rohde; Barbara Starfield
Journal:  Med Decis Making       Date:  2006 Jan-Feb       Impact factor: 2.583

6.  Overcoming the barriers to diagnosis of Morquio A syndrome.

Authors:  Kaustuv Bhattacharya; Shanti Balasubramaniam; Yew Sing Choy; Michael Fietz; Antony Fu; Dong Kyu Jin; Ok-Hwa Kim; Motomichi Kosuga; Young Hee Kwun; Anita Inwood; Hsiang-Yu Lin; Jim McGill; Nancy J Mendelsohn; Torayuki Okuyama; Hasri Samion; Adeline Tan; Akemi Tanaka; Verasak Thamkunanon; Teck-Hock Toh; Albert D Yang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

7.  Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.

Authors:  Vanessa L Merker; Annie Dai; Heather B Radtke; Pamela Knight; Justin T Jordan; Scott R Plotkin
Journal:  BMC Health Serv Res       Date:  2018-08-29       Impact factor: 2.655

8.  Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study.

Authors:  Simon Ronicke; Martin C Hirsch; Ewelina Türk; Katharina Larionov; Daphne Tientcheu; Annette D Wagner
Journal:  Orphanet J Rare Dis       Date:  2019-03-21       Impact factor: 4.123

9.  Diagnostic test interpretation and referral delay in patients with interstitial lung disease.

Authors:  David Pritchard; Ayodeji Adegunsoye; Elyse Lafond; Janelle Vu Pugashetti; Ryan DiGeronimo; Noelle Boctor; Nandini Sarma; Isabella Pan; Mary Strek; Michael Kadoch; Jonathan H Chung; Justin M Oldham
Journal:  Respir Res       Date:  2019-11-12

10.  Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.

Authors:  Julie B Eisengart; Kyle D Rudser; Yong Xue; Paul Orchard; Weston Miller; Troy Lund; Ans Van der Ploeg; Jean Mercer; Simon Jones; Karl Eugen Mengel; Seyfullah Gökce; Nathalie Guffon; Roberto Giugliani; Carolina F M de Souza; Elsa G Shapiro; Chester B Whitley
Journal:  Genet Med       Date:  2018-03-08       Impact factor: 8.822

View more
  3 in total

1.  Diagnostic Process in Rare Diseases: Determinants Associated with Diagnostic Delay.

Authors:  Juan Benito-Lozano; Greta Arias-Merino; Mario Gómez-Martínez; Alba Ancochea-Díaz; Aitor Aparicio-García; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

2.  Factors affecting pathways to care for children and adolescents with complex vascular malformations: parental perspectives.

Authors:  Bryan A Sisk; Anna Kerr; Katherine A King
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

3.  So, and if it is not congenital adrenal hyperplasia? Addressing an undiagnosed case of genital ambiguity.

Authors:  Reinaldo Luna de Omena Filho; Reginaldo José Petroli; Fernanda Caroline Soardi; Débora de Paula Michelatto; Taís Nitsch Mazzola; Helena Fabbri-Scallet; Maricilda Palandi de Mello; Susane Vasconcelos Zanotti; Ida Cristina Gubert; Isabella Monlleo
Journal:  Ital J Pediatr       Date:  2022-06-10       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.